White House Withdraws Nomination of Heidi Overton for FDA Commissioner
The White House on Tuesday pulled the nomination of Dr. Heidi Overton to lead the U.S. Food and Drug Administration (FDA), after pro-life groups and Senators raised concerns over the Trump administration’s failure to restrict use of the abortion pill.
President Trump nominated Dr. Overton to lead the FDA in August, following the resignation of Commissioner Marty Makary, who left the post in May. Attorney Kyle Diamantas has served as FDA acting commissioner ever since, including while the Senate considered Dr. Overton’s nomination.
“Tonight, the White House abandoned a viable confirmation path for Dr. Overton. The WH said that this was because she did not have the votes to pass,” wrote U.S. Senator Bill Cassidy, who is leaving office in January and chairs the Senate health committee. “This was odd as I was having productive conversations with members. I believe she would have had the votes to pass out of committee and pass the full Senate.”
When President Trump first selected Dr. Overton to head the FDA, she was seen as a solid pick who is friendly to the pro-life movement.
In 2022, she called the Dobbs decision and the overturning of Roe v. Wade “a huge victory for life.” She added, “Human life is not disposable, but a precious gift from God with inherent worth and dignity.”
At the same time, in a column for The Daily Caller, Dr. Overton criticized the Biden administration’s Department of Health and Human Services detailing the various stages of human development during pregnancy and simultaneously supporting abortion up until birth.
“It should be clear where the radicalism lies,” Dr. Overton wrote. “Americans should reject abortion radicalism and require policies informed by 21st century science and medicine. Then, indeed, we would all be ‘Following the Science!’”
Despite Dr. Overton’s pro-life views, several pro-life organizations and leaders demanded the Senate not confirm her until she committed to restoring safeguards on the abortion pill, like stopping mifepristone from being sent through the mail.
“Dr. Heidi Overton [must] commit to restoring the safeguards governing mifepristone that existed before the Biden administration while the FDA completes its ongoing review of the drug,” 50 leading pro-life groups wrote in a joint statement.
The groups’ frustration stems from the Trump administration’s failure to crack down on the abortion pill, rather than with Dr. Overton herself.
The FDA initially launched a study into mifepristone’s safety in 2025, which was reportedly set to conclude in September 2026. But the study’s release has been delayed to at least March 2027. In the meantime, thousands of women are put at risk and preborn children are killed.
Last year, a study by the Ethics and Public Policy Center (EPPC) found that nearly 11% of all women who abort their children with mifepristone suffer from serious health complications, including sepsis, infection or hemorrhaging.
But to date, the Trump administration’s FDA has not changed mifepristone’s regulations, even after the Biden administration’s FDA allowed mifepristone to be sent through the mail and dispensed at retail pharmacies like Walgreens.
Before her nomination was withdrawn, Dr. Overton had been making progress in persuading Senators to confirm her, Senator Cassidy shared.
“[But] pro-life Senators sought final assurances from the Administration regarding the Administration’s commitment to life issues [before confirming her],” Cassidy said. “The Administration withdrew Dr. Overton rather than make such commitments. Unfortunately, with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats.”
Only weeks remain before the 120th U.S. Congress begins on January 3, 2027, and Democrats regain control of both the House and Senate.
Since whoever President Trump selects to serve as the next FDA commissioner will have to be confirmed by a Democrat-controlled Senate, it’s very unlikely a nominee friendly to the pro-life movement will take the reins at the FDA.
To truly “follow the science” and “Make America Healthy Again,” the FDA must reinstate safety guardrails on the abortion pill.
If you are experiencing an unexpected pregnancy and want to learn more about your options, you can visit My Choice Network.
Related articles and resources:
Dealing With Unplanned Pregnancy
Become an Option Ultrasound Life Advocate
New Insights on the Dangers of the Abortion Pill
Overcoming Abortion and Becoming a Force for Life
FDA Delays Review of Abortion Pill, Leaving Women Unprotected
Pro-Life Groups Urge FDA to Restore Abortion Pill Safeguards
FDA Commissioner Nominee Heidi Overton Boasts Strong Pro-Life Background
Photo from Getty Images.
ABOUT THE AUTHOR

Zachary Mettler is a writer/analyst for Daily Citizen at Focus on the Family. In his role, he writes about current political issues, U.S. history, political philosophy, and culture. Mettler earned his Bachelor’s degree from William Jessup University and is an alumnus of the Young Leaders Program at The Heritage Foundation. In addition to Daily Citizen, his written pieces have appeared in the Daily Wire, the Washington Times, the Washington Examiner, Newsweek, Townhall, the Daily Signal, the Christian Post, Charisma News and other outlets.
Related Posts

Pope Leo XIV: The Unborn Already Belong to the Human Family
November 12, 2026

New Federal Bill Would Require Abortionists to Provide Burial or Cremation for Aborted Babies
November 9, 2026

Republicans Must Defund Planned Parenthood This Year
November 6, 2026

The Judicial Branch’s Future After the 2026 Midterm Election
November 4, 2026